Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Sandri

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
JACC. Cardiovascular Interventions|November 15, 2020
Procedural and Short-Term Results With the New Watchman FLX Left Atrial Appendage Occlusion DeviceIgnacio Cruz-González, Kasper Korsholm, Blanca Trejo-Velasco, et al.
JAMA Cardiology|August 27, 2020
Association of Culprit Lesion Location With Outcomes of Culprit-Lesion-Only vs Immediate Multivessel Percutaneous Coronary Intervention in Cardiogenic Shock: A Post Hoc Analysis of a Randomized Clinical TrialSerdar Farhan, Birgit Vogel, Gilles Montalescot, et al.
Trends in Cardiovascular Medicine|September 13, 2018
An overview of current and emerging devices for percutaneous left atrial appendage closureDanny H F Chow, Yam-Hong Wong, Jai-Wun Park, et al.
JACC. Cardiovascular Interventions|May 23, 2020
Prognostic Value of SYNTAX Score in Patients With Infarct-Related Cardiogenic Shock: Insights From the CULPRIT-SHOCK TrialPaul Guedeney, Olivier Barthélémy, Michel Zeitouni, et al.
American Heart Journal|November 30, 2020
Impact of chronic total occlusion and revascularization strategy in patients with infarct-related cardiogenic shock: A subanalysis of the culprit-shock trialNassim Braik, Paul Guedeney, Micheal Behnes, et al.
American Heart Journal|May 10, 2026
Left Atrial Appendage closure in patients with non-valvular atrial fibrillation and end stage chronic KIDNEY disease: Rationale and design of the prospective randomized LAA-KIDNEY trialRoza Saraei, Gunnar Heine, Pavel Osmancik, et al.
Circulation Research|February 4, 2021
Molecular Mechanisms of Diaphragm Myopathy in Humans With Severe Heart FailureNorman Mangner, Jens Garbade, Estelle Heyne, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 22, 2023
Left atrial appendage closure in end-stage renal disease and hemodialysis: Data from a German multicenter registryThomas Fink, Christina Paitazoglou, Martin W Bergmann, et al.
American Heart Journal|June 5, 2020
Radial versus femoral artery access for percutaneous coronary artery intervention in patients with acute myocardial infarction and multivessel disease complicated by cardiogenic shock: Subanalysis from the CULPRIT-SHOCK trialPaul Guedeney, Holger Thiele, Mathieu Kerneis, et al.
Circulation|November 5, 2021
Comparison of a Pure Plug-Based Versus a Primary Suture-Based Vascular Closure Device Strategy for Transfemoral Transcatheter Aortic Valve Replacement: The CHOICE-CLOSURE Randomized Clinical TrialMohamed Abdel-Wahab, Philipp Hartung, Oliver Dumpies, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
JACC. Cardiovascular Interventions|November 15, 2020
Procedural and Short-Term Results With the New Watchman FLX Left Atrial Appendage Occlusion DeviceIgnacio Cruz-González, Kasper Korsholm, Blanca Trejo-Velasco, et al.
JAMA Cardiology|August 27, 2020
Association of Culprit Lesion Location With Outcomes of Culprit-Lesion-Only vs Immediate Multivessel Percutaneous Coronary Intervention in Cardiogenic Shock: A Post Hoc Analysis of a Randomized Clinical TrialSerdar Farhan, Birgit Vogel, Gilles Montalescot, et al.
Trends in Cardiovascular Medicine|September 13, 2018
An overview of current and emerging devices for percutaneous left atrial appendage closureDanny H F Chow, Yam-Hong Wong, Jai-Wun Park, et al.
JACC. Cardiovascular Interventions|May 23, 2020
Prognostic Value of SYNTAX Score in Patients With Infarct-Related Cardiogenic Shock: Insights From the CULPRIT-SHOCK TrialPaul Guedeney, Olivier Barthélémy, Michel Zeitouni, et al.
American Heart Journal|November 30, 2020
Impact of chronic total occlusion and revascularization strategy in patients with infarct-related cardiogenic shock: A subanalysis of the culprit-shock trialNassim Braik, Paul Guedeney, Micheal Behnes, et al.
American Heart Journal|May 10, 2026
Left Atrial Appendage closure in patients with non-valvular atrial fibrillation and end stage chronic KIDNEY disease: Rationale and design of the prospective randomized LAA-KIDNEY trialRoza Saraei, Gunnar Heine, Pavel Osmancik, et al.
Circulation Research|February 4, 2021
Molecular Mechanisms of Diaphragm Myopathy in Humans With Severe Heart FailureNorman Mangner, Jens Garbade, Estelle Heyne, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 22, 2023
Left atrial appendage closure in end-stage renal disease and hemodialysis: Data from a German multicenter registryThomas Fink, Christina Paitazoglou, Martin W Bergmann, et al.
American Heart Journal|June 5, 2020
Radial versus femoral artery access for percutaneous coronary artery intervention in patients with acute myocardial infarction and multivessel disease complicated by cardiogenic shock: Subanalysis from the CULPRIT-SHOCK trialPaul Guedeney, Holger Thiele, Mathieu Kerneis, et al.
Circulation|November 5, 2021
Comparison of a Pure Plug-Based Versus a Primary Suture-Based Vascular Closure Device Strategy for Transfemoral Transcatheter Aortic Valve Replacement: The CHOICE-CLOSURE Randomized Clinical TrialMohamed Abdel-Wahab, Philipp Hartung, Oliver Dumpies, et al.
Pageof 9